Institutional investors purchased a net $62.9 thousand shares of DXCM during the quarter ended March 2018 and now own 118.63% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.9 Million shares of DexCom Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 914.0 Thousand shares of DexCom Inc
ROCKEFELLER & CO., INC. Bought 913.3 Thousand shares of DexCom Inc